Achievable logoAchievable logo
Series 7
Sign in
Sign up
Purchase
Textbook
Practice exams
Support
How it works
Resources
Exam catalog
Mountain with a flag at the peak
Textbook
Introduction
1. Common stock
1.1 Introduction and SIE review
1.2 Equity securities & trading
1.2.1 Rights & warrants
1.2.2 Stock splits & dividends
1.2.3 American depositary receipts (ADRs)
1.2.4 Foreign investments
1.2.5 Corporate actions
1.2.6 Tender offers
1.2.7 The primary & secondary market
1.2.8 Cash dividends
1.3 Suitability
1.4 Fundamental analysis
1.5 Technical analysis
2. Preferred stock
3. Bond fundamentals
4. Corporate debt
5. Municipal debt
6. US government debt
7. Investment companies
8. Alternative pooled investments
9. Options
10. Taxes
11. The primary market
12. The secondary market
13. Brokerage accounts
14. Retirement & education plans
15. Rules & ethics
16. Suitability
Wrapping up
Achievable logoAchievable logo
1.2.1 Rights & warrants
Achievable Series 7
1. Common stock
1.2. Equity securities & trading

Rights & warrants

11 min read
Font
Discuss
Share
Feedback

We’ll cover rights and warrants in this section. Both are equity-related securities that let you buy common stock at a fixed price. They look similar on the surface, but the differences show up often on the exam.

Rights

As we discussed in the common stock review, authorized shares are set when the company is formed. This is the maximum number of shares the company is allowed to sell to investors. If a company authorizes 1 million shares, it can sell up to 1 million shares of stock. Companies give up ownership (stock) in exchange for capital (money).

Most companies don’t sell all of their authorized shares during their initial public offering (the first public sale of their shares). That leaves room to raise additional capital later by selling the remaining authorized shares.

The number of shares a company sells during its initial public offering (IPO) is called issued shares. Once shares are issued, they trade in the secondary market among investors.

Assume a company authorizes 1 million shares but issues 500,000 shares. Now assume you purchase 50,000 shares. That’s a 10% ownership position because you own 50,000 out of 500,000 outstanding shares.

Several years later, the company needs to raise additional capital. It still has 500,000 authorized shares available to sell, so it decides to issue all of them. If you don’t buy any of the new shares, your ownership percentage is diluted from 10% to 5%.

Shares owned Shares outstanding Percent ownership
Before 50,000 500,000 10%
Diluted 50,000 1,000,000 5%

Your percent ownership fell from 10% to 5% simply because more shares were issued. That also reduces your voting power. To prevent this kind of dilution without giving current owners a chance to maintain their stake, companies must offer the new shares to existing stockholders first.

This is the pre-emptive right: current stockholders have the right to buy newly issued shares before they’re offered to the public. In our example, you owned 10% of the outstanding shares. Before the public sale, you’ll have the opportunity to buy 10% of the new offering so you can keep the same ownership percentage.

Here’s how it works:

  • The company distributes rights to current stockholders.
  • Investors receive one right for each share of stock owned.
  • A certain number of rights are required to buy one new share (the exam will tell you the ratio).

You owned 50,000 shares, so you receive 50,000 rights. Each right has a value because it lets you buy stock at a discount.

For this rights distribution, assume:

  • 1 right needed to purchase 1 new share
  • Current market price of stock = $50
  • Rights exercise price = $40

Rights have intrinsic value, meaning they’re worth something immediately. Each right lets you buy one new share for $40 when the market price is $50. That’s a $10 discount, so the right is issued with $10 of intrinsic value.

One reason companies can offer shares at a discount in a rights offering is that they may avoid using an underwriter.

You learned about underwriters when you prepared for the SIE exam. As a refresher, underwriters help organizations market and sell securities to the public. For example, when Facebook went public in 2012, it hired Morgan Stanley, JP Morgan, and Goldman Sachs as lead underwriters.

Facebook didn’t have the distribution network to sell its stock directly into the financial markets, so it used large investment banks (underwriters). Underwriting is expensive; Facebook’s underwriters collected hundreds of millions of dollars for their services.

If a company sells new shares primarily to current stockholders through a rights offering, it may not need an underwriter. The cost savings can show up as a discounted subscription (exercise) price.

When you receive rights, you have a few choices:

  • Exercise the rights and buy the new shares at the exercise price
  • Sell (trade) the rights in the market (because they have value)
  • Let the rights expire

Rights don’t last forever. They typically expire within 60-90 days of issuance. If you let them expire, you receive no benefit from them.

Sidenote
Case study: Bain Capital rights offering

To better understand rights, let’s analyze a real-world rights offering conducted by Bain Capital (ticker: BCSF):

The Company will issue to stockholders of record on May 13, 2020 transferable rights to subscribe for an aggregate of up to 12.9 million shares of the Company’s common stock. Record stockholders will receive one right for each share of common stock owned on the record date. The rights will entitle the holders to purchase one new share of common stock for every four rights held.

The subscription price for the shares to be issued pursuant to the rights offering will be 92.5% of the volume-weighted average of the market price of the Company’s shares of common stock on the New York Stock Exchange (NYSE) for the five consecutive trading days ending on the Expiration Date.

Bain Capital is offering up to 12.9 million additional shares and giving current shareholders the first opportunity to buy them.

  • Stockholders of record (settled shareholders) on May 13, 2020 receive the rights.
  • The rights are transferable, meaning shareholders can exercise them, trade them, or let them expire.
  • Shareholders receive one right per share owned.
  • Four rights are needed to buy one new share.
  • The subscription price is 92.5% of the market price (a discount).

Let’s assume an investor owns 100 shares of Bain Capital, and the stock is trading at $10 per share. How many shares can the investor purchase, and what price will they pay per share?

(spoiler)

Answer: 25 shares at $9.25/share

The investor owns 100 shares, so they receive 100 rights. They can purchase one new share for four rights.

4 rights for each new share100 shares owned​ = 25 new shares

The subscription price is 92.5% of the market price, which is $10 per share.

Subscription price=$10 x 92.5%

Subscription price=$9.25

If an investor wants to trade rights in the secondary market, two formulas are used to estimate the value of a right.

If the stock is trading cum-rights (with rights; before the ex-date for rights), use:

Cum-right value=rights needed per new share +1market price - subscription price​

Trading cum-rights means the stock still includes the rights. In the case study above, this formula applies prior to May 13, 2020 (the ex-date for the rights distribution).

With the record date being May 13th, the investor must purchase the stock by May 12th to receive the rights (T+1 settlement). If the stock is purchased on May 13th (ex-date), the investor will not receive the rights.

Using the case study information:

  • Market price = $10
  • Subscription price = $9.25
  • Rights needed per new share = 4

What is the value of the right (cum-rights)?

(spoiler)

Answer: $0.15

Cum-right value=rights needed per new share +1market price - subscription price​

Cum-right value=4 +1$10 - $9.25​

Cum-right value=5$0.75​

Cum-right value=$0.15

On the ex-date for the rights distribution, the stock price typically falls because the stock no longer includes the rights. The formula changes to reflect that the stock is now trading ex-rights (without rights):

Ex-right value=rights needed per new sharemarket price - subscription price​

The only difference between the formulas is whether you add 1 in the denominator.

Assuming the market price falls slightly, try an ex-rights calculation:

  • Market price = $9.85
  • Subscription price = $9.25
  • Rights needed per new share = 4

What is the value of the right (ex-rights)?

(spoiler)

Answer: $0.15

Ex-right value=rights needed per new sharemarket price - subscription price​

Ex-right value=4$9.85 - $9.25​

Ex-right value=4$0.60​

Ex-right value=$0.15

The value of a right won’t always be exactly the same from cum-rights to ex-rights, but it can happen.

Try to keep these formulas as simple as possible. The key difference is whether 1 is added to the denominator. A quick memory aid is word association: “cum” is Latin for “with,” and “ex” is Latin for “without.” In the cum-rights formula, add 1 (with). In the ex-rights formula, don’t add 1 (without).

By offering pre-emptive rights, companies give stockholders a way to maintain their percent ownership of outstanding shares. If a stockholder exercises all their rights, their ownership percentage is not diluted.

Warrants

Warrants are similar to rights because they also give the holder the right to purchase shares from a publicly traded company at a fixed price. Let’s look at the key characteristics of warrants, then compare them with rights.

Assume a company’s stock is trading at $50. A warrant will have a fixed exercise price, but it’s typically set above the current market price. For example, a warrant might have an exercise price of $60. At issuance, it usually doesn’t make sense to exercise the warrant because you could buy the stock in the market for $50 instead of paying $60.

Warrants have time value, meaning their value comes largely from how long they last. Warrants often don’t expire for five or more years. The $60 exercise price stays fixed, but the market price can change. If the market price rises to $80 after a few years, the right to buy at $60 becomes valuable.

Warrants are often issued as a sweetener when selling another security. For example, if a company is having trouble marketing a new bond, it may attach a warrant to make the bond more attractive. The idea is similar to a “bonus item” in a promotion: buy the bond, and you also receive a warrant.

Issuing warrants is a dilutive action. If the warrants are exercised, new shares are created, which can dilute existing ownership. Because of that, issuing warrants requires stockholder approval.

Rights vs. warrants

In conclusion, warrants are similar to rights but have important differences. Here are the key exam points:

Rights

  • Right to purchase new shares at a fixed price
  • Intrinsic value exists at issuance
  • Little time value at issuance
  • Short term (typically 60-90 days or less)
  • Possible outcomes for rights:
    • Exercise
    • Trade
    • Expire

Warrants

  • Right to purchase new shares at a fixed price
  • No intrinsic value at issuance
  • Significant time value at issuance
  • Long term (typically 5 years or longer)
  • Possible outcomes for warrants:
    • Exercise
    • Trade
    • Expire

Additionally, here’s a video that will help you understand the type of question to expect on rights and warrants:

Key points

Rights

  • Right to purchase new shares at a fixed price
  • Provided to current stockholders during additional offerings
  • One right for every share owned
  • Intrinsic value exists
  • Little time value
  • Short term (typically 90 days or less)
  • Possible outcomes:
    • Exercise
    • Trade
    • Expire

Rights value (cum-rights) formula

  • Rights needed per new share +1Market price - subscription price​
  • Used prior to ex-date

Rights value (ex-rights) formula

  • Rights needed per new shareMarket price - subscription price​
  • Used on or after ex-date

Warrants

  • Right to purchase new shares at a fixed price
  • Issued as a sweetener with other securities
  • No intrinsic value
  • Time value exists
  • Long term (typically 5 years or longer)
  • Possible outcomes:
    • Exercise
    • Trade
    • Expire

Issuing warrants

  • Dilutive action requiring stockholder approval

Sign up for free to take 8 quiz questions on this topic

All rights reserved ©2016 - 2026 Achievable, Inc.